Drug
Nivatrotamab
Nivatrotamab: highest development phase Phase 1/2, developed by Y-mAbs Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Y-mAbs Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nivatrotamab NCT04750239 | Phase 1/2 | SCLC |
Latest
No recent events.
Follow Nivatrotamab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.